A Switch Clinical Trial of Antiretrovirals to Compare the Impact of Doravirine Versus Integrase Inhibitors With Backbone of Emtricitabine and Tenofovir Alafenamide on Instigators of Atherosclerosis in Persons With Chronic Treated HIV.
Latest Information Update: 15 Mar 2024
At a glance
- Drugs Doravirine (Primary) ; Emtricitabine; Tenofovir alafenamide
- Indications HIV-1 infections
- Focus Pharmacodynamics
- 07 Mar 2024 Status changed from not yet recruiting to recruiting.
- 29 Nov 2023 Planned initiation date changed from 1 Nov 2023 to 1 Feb 2024.
- 01 Oct 2023 Planned initiation date changed from 1 Sep 2023 to 1 Nov 2023.